Trials / Conditions / Recurrent High Grade Ovarian Serous Adenocarcinoma
Recurrent High Grade Ovarian Serous Adenocarcinoma
3 registered clinical trials studyying Recurrent High Grade Ovarian Serous Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients NCT05114421 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Ca NCT03610490 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surg NCT02898207 | National Cancer Institute (NCI) | Phase 1 |